Ruxolitinib
- Introduction
- Newest Products
Introduction
Ruxolitinib
Ruxolitinib is an anti-tumor drug for the treatment of myeloproliferative neoplasm-associated myelofibrosis, further myeloproliferative neoplasms, polycythemia vera and refractory cancer.
Newest Products
| Image | Part # | Description | manufacturer | Stock | RFQ | |
|---|---|---|---|---|---|---|
|
|
Ruxolitinib Phosphate (1092939-17-7) |
CAS: 1092939-17-7; Ruxolitinib manufacturer; Ruxolitinib API; Anti-Tumor
|
|
In Stock
|
|
|
|
|
4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine (941685-26-3) |
CAS: 941685-26-3; Ruxolitinib manufacturer; Ruxolitinib intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
3-cyclopentylacrylonitrile (591769-05-0) |
CAS: 591769-05-0; Ruxolitinib manufacturer; Ruxolitinib intermediate; Anti-Tumor
|
|
In Stock
|
|
